HomeCompareOCTHF vs ORCC

OCTHF vs ORCC: Dividend Comparison 2026

OCTHF yields 71428.57% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OCTHF wins by $1.6804617092236922e+25M in total portfolio value
10 years
OCTHF
OCTHF
● Live price
71428.57%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.6804617092236922e+25M
Annual income
$16,758,464,082,723,930,000,000,000,000,000.00
Full OCTHF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — OCTHF vs ORCC

📍 OCTHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOCTHFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OCTHF + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OCTHF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OCTHF
Annual income on $10K today (after 15% tax)
$6,071,428.57/yr
After 10yr DRIP, annual income (after tax)
$14,244,694,470,315,339,000,000,000,000,000.00/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, OCTHF beats the other by $14,244,694,470,315,339,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OCTHF + ORCC for your $10,000?

OCTHF: 50%ORCC: 50%
100% ORCC50/50100% OCTHF
Portfolio after 10yr
$8.402308546118461e+24M
Annual income
$8,379,232,041,361,964,000,000,000,000,000.00/yr
Blended yield
99.73%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

OCTHF
No analyst data
Altman Z
-28.5
Piotroski
3/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OCTHF buys
0
ORCC buys
18
PoliticianChamberTickerTypeAmountDate
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-23
Trey Hollingsworth🏢 House$ORCC▲ Buy$250,001 - $500,0002022-06-16
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-14
Trey Hollingsworth🏢 House$ORCC▲ Buy$50,001 - $100,0002022-06-13
Trey Hollingsworth🏢 House$ORCC▲ Buy$50,001 - $100,0002022-06-10
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-09
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-08
Trey Hollingsworth🏢 House$ORCC▲ Buy$50,001 - $100,0002022-06-03
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-05-24
Trey Hollingsworth🏢 House$ORCC▲ Buy$100,001 - $250,0002022-05-20
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOCTHFORCC
Forward yield71428.57%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$1.6804617092236922e+25M$21.4K
Annual income after 10y$16,758,464,082,723,930,000,000,000,000,000.00$1.04
Total dividends collected$1.6801590475897682e+25M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: OCTHF vs ORCC ($10,000, DRIP)

YearOCTHF PortfolioOCTHF Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$7,153,557$7,142,857.14$11,190$489.61+$7.14MOCTHF
2$4,783,059,608$4,775,405,302.31$12,229$256.01+$4783.05MOCTHF
3$2,989,196,089,253$2,984,078,215,471.53$13,216$130.74+$2989196.08MOCTHF
4$1,746,108,740,720,723$1,742,910,300,905,223.00$14,207$66.02+$1746108740.71MOCTHF
5$953,366,906,359,837,700$951,498,570,007,266,600.00$15,234$33.17+$953366906359.82MOCTHF
6$486,546,837,026,708,500,000$485,526,734,436,903,500,000.00$16,317$16.62+$486546837026708.50MOCTHF
7$232,096,820,383,666,640,000,000$231,576,215,268,048,070,000,000.00$17,468$8.32+$232096820383666624.00MOCTHF
8$103,489,940,016,498,150,000,000,000$103,241,596,418,687,620,000,000,000.00$18,695$4.16+$103489940016498147328.00MOCTHF
9$43,133,653,750,454,530,000,000,000,000$43,022,919,514,636,880,000,000,000,000.00$20,006$2.08+$4.313365375045453e+22MOCTHF
10$16,804,617,092,236,920,000,000,000,000,000$16,758,464,082,723,930,000,000,000,000,000.00$21,407$1.04+$1.6804617092236922e+25MOCTHF

OCTHF vs ORCC: Complete Analysis 2026

OCTHFStock

Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate is OCT461201, a selective CB2 receptor agonist in solid oral dosage form that is in pre-clinical development for use in the treatment of IBS-associated visceral pain, as well as neuropathic pain conditions, including post herpetic neuralgia. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.

Full OCTHF Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this OCTHF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OCTHF vs SCHDOCTHF vs JEPIOCTHF vs OOCTHF vs KOOCTHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.